127 related articles for article (PubMed ID: 37078214)
1. [Expression level of miR-199b in human colorectal cancer tissues and its correlation with clinicopathological features and prognosis of patients].
Ma X; Yuan W; Ma J
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):330-334. PubMed ID: 37078214
[No Abstract] [Full Text] [Related]
2. Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma.
Tan B; Guo J; Wang L; Wang L; Gan X; Chen B
Exp Mol Pathol; 2021 Jun; 120():104643. PubMed ID: 33932399
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
Zhou T; Zhang G; Liu Z; Xia S; Tian H
Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
Fang C; Wang FB; Li Y; Zeng XT
Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
7. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
Wang Y; Yuan W; Ma X; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
[No Abstract] [Full Text] [Related]
8. Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.
Wang LL; Du LT; Li J; Liu YM; Qu AL; Yang YM; Zhang X; Zheng GX; Wang CX
World J Gastroenterol; 2014 Aug; 20(32):11340-6. PubMed ID: 25170220
[TBL] [Abstract][Full Text] [Related]
9. [Expression of microRNA-29b in colorectal cancer and its relationship with clinicopathological features].
Ma X; Yuan W; Tang WY; Ma J
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):430-3. PubMed ID: 27346400
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of miR-199b in cancers: a meta-analysis.
Mao Z; Liu R; Zhang M; Liu W; Li D; Li H
Biomark Med; 2022 Aug; 16(11):879-888. PubMed ID: 35704299
[No Abstract] [Full Text] [Related]
11. Prognostic significance of microRNA-16 expression in human colorectal cancer.
Qian J; Jiang B; Li M; Chen J; Fang M
World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
Cristóbal I; Caramés C; Rincón R; Manso R; Madoz-Gúrpide J; Torrejón B; González-Alonso P; Rojo F; García-Foncillas J
Oncotarget; 2017 Jun; 8(25):40169-40180. PubMed ID: 27517624
[TBL] [Abstract][Full Text] [Related]
15. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
[TBL] [Abstract][Full Text] [Related]
16. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
17. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Wang X; Wang J; Ma H; Zhang J; Zhou X
Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-466 (miR-466) functions as a tumor suppressor and prognostic factor in colorectal cancer (CRC).
Tong F; Ying Y; Pan H; Zhao W; Li H; Zhan X
Bosn J Basic Med Sci; 2018 Aug; 18(3):252-259. PubMed ID: 29338680
[TBL] [Abstract][Full Text] [Related]
20. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
